Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease

참고문헌 (11)

1. Nadia Soledad Alegre, "Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 26(2), pp.216~226 (2020), 대한간학회[DOI]
2. Haas JT, "Pathophysiology and mechanisms of nonalcoholic fatty liver disease", Annu Rev Phys, 78, pp.181~205 (2016)
3. Petta S, "Pathophysiology of non alcoholic fatty liver disease", Int J Mol Sci, 17, pp.2082~ (2016)
4. Mahla RS, "Sweeten PAMPs : role of sugar complexed PAMPs in innate immunity and vaccine biology", Front Immunol, 4, pp.248~ (2013)
5. Miura K, "Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice", Gastroenterology, 139, pp.323~334.e7 (2010)
6. Sharifnia T, "Hepatic TLR4 signaling in obese NAFLD", Am J Physiol Gastrointest Liver Physiol, 309, pp.G270~G278 (2015)
7. Vijay-Kumar M, "Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5", Science, 328, pp.228~231 (2010)
8. Szabo G, "Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice : the role of toll-like receptors 2 and 4", Alcohol Clin Exp Res, 29(11 Suppl), pp.140S~145S (2005)
9. Rau M, "Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17", resting regulatory T cell ratio in peripheral blood and in the liver, 2016, pp.196, 97~105
10. Yu Y, "STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis", J Clin Invest, 129, pp.546~555 (2019)
11. Kolodziejczyk AA, "The role of the microbiome in NAFLD and NASH", EMBO Mol Med, 11, pp.e9302~ (2019)

관련 논문AI추천